Are Options Traders Bullish on ATNX?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ATNX

Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery and development of next generation drugs for the treatment of cancer. Athenex is organized around three platforms including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. Athenexs Oncology Innovation Platform generates clinical candidates through an extensive understanding of kinases, including novel binding sites, human absorption biology and through the application of Athenexs proprietary research and selection processes in the lab. The Companys current clinical pipeline is derived from two different platform technologies Athenex calls Orascovery and Src Kinase Inhibition. The Orascovery platform is based on the novel oral P-glycoprotein pump inhibitor molecule HM30181A, through which Athenex is able to facilitate oral absorption of traditional cytotoxics, which Athenex believes may offer improved patient tolerability and efficacy as compared to IV administration of the same cytotoxics. The Src Kinase Inhibition platform refers to novel small molecule compounds that have multiple mechanisms of action, including the inhibition of the activity of Src Kinase and the inhibition of tubulin polymerization during cell division. Athenex believes the combination of these mechanisms of action provides a broader range of anti-cancer activity as compared to either mechanism of action alone.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ATNX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 283.8 M 2.83842E+08 202 202 0.05% 0.000498839 294 K 293534
EQWS Invesco Russell 2000 Equal Weight ETF 20.8 M 2.08E+07 1,977 1977 0.02% 0.00024 5 K 4971
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 347 347 0.01% 9.15586E-05 146 K 146324
IBB iShares Nasdaq Biotechnology Index Fund 8.0 B 8.00963E+09 191 191 0.11% 0.0011 9.1 M 9135010
IWM iShares Russell 2000 ETF 44.5 B 4.44813E+10 2,022 2022 0.02% 0.0002 11.2 M 1.12268E+07
IWO iShares Russell 2000 Growth ETF 9.0 B 8.98678E+09 1,240 1240 0.05% 0.0005 4.8 M 4817570
IWV iShares Russell 3000 ETF 8.4 B 8.38911E+09 3,006 3006 0.0% 0 153 K 153248
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 1,029 1029 0.01% 9.52995E-05 174 K 173686
UBIO Proshares UltraPro Nasdaq Biotechnology 28.8 M 2.87594E+07 196 196 0.02% 0.000234123 22 K 22264
URTY ProShares UltraPro Russell2000 108.8 M 1.08826E+08 2,033 2033 0.0% 4.79747E-05 18 K 17635
UWM ProShares Ultra Russell2000 162.8 M 1.62825E+08 2,033 2033 0.01% 0.000105252 37 K 36624
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.4 B 4.43077E+09 126 126 0.22% 0.00217042 9.5 M 9452423

Wait, Before You Leave...